Fyn, a potential target for alzheimer's disease

Journal of Alzheimer's Disease

Volumn 27, Issue 2, 2011, Pages 243-252

  Yang, Kai ^a   Belrose, Jillian ^b   Trepanier, Catherine H ^c   Lei, Gang ^d   Jackson, Michael F ^b,d   MacDonald, John F ^a,b,c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

Alzheimer's disease; AMPA receptors; amyloid ; Fyn; NMDA receptors; synaptic plasticity; tau

Indexed keywords

AMYLOID BETA PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN KINASE FYN; TAU PROTEIN;

ALZHEIMER DISEASE; AMNESIA; ENZYME REGULATION; ENZYME STRUCTURE; HUMAN; LEARNING; LONG TERM DEPRESSION; LONG TERM POTENTIATION; NERVE CELL PLASTICITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SYNAPTIC TRANSMISSION;

EID: 81855168411     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-110353     Document Type: Review

References (111)

1. Citron M (2010) Alzheimer's disease: Strategies for disease modification. Nat Rev Drug Discov 9, 387-398.
2. LaFerla FM, Green KN, Oddo S (2007) Intracellular amyloid-beta in Alzheimer's disease. Nat Rev Neurosci 8, 499-509.
3. Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8, 101-112. (Pubitemid 46432529)
4. Ballatore C, Lee VM, Trojanowski JQ (2007) Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci 8, 663-672. (Pubitemid 47283144)
5. Wang JZ, Liu F (2008) Microtubule-associated protein tau in development, degeneration and protection of neurons. Prog Neurobiol 85, 148-175.
6. Shirazi SK, Wood JG (1993) The protein tyrosine kinase, Fyn, in Alzheimer's disease pathology. Neuroreport 4, 435-437. (Pubitemid 23116742)
7. Ho GJ, Hashimoto M, Adame A, Izu M, Alford MF, Thal LJ, Hansen LA, Masliah E (2005) Altered p59Fyn kinase expression accompanies disease progression in Alzheimer's disease: Implications for its functional role. Neurobiol Aging 26, 625-635. (Pubitemid 40228754)
8. Chin J, Palop JJ, Yu GQ, Kojima N, Masliah E, Mucke L (2004) Fyn kinase modulates synaptotoxicity, but not aberrant sprouting, in human amyloid precursor protein transgenic mice. J Neurosci 24, 4692-4697. (Pubitemid 38656624)
9. Chin J, Palop JJ, Puolivali J, Massaro C, Bien-Ly N, Gerstein H, Scearce-Levie K, Masliah E, Mucke L (2005) Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer's disease. J Neurosci 25, 9694-9703. (Pubitemid 41510910)
10. Venkitaramani DV, Chin J, Netzer WJ, Gouras GK, Lesne S, Malinow R, Lombroso PJ (2007) Beta-amyloid modulation of synaptic transmission and plasticity. J Neurosci 27, 11832-11837. (Pubitemid 350072092)
11. Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, van, Eersel J, Wolfing H, Chieng BC, Christie MJ, Napier IA, Eckert A, Staufenbiel M, Hardeman E, Gotz J (2010) Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell 142, 387-397.
12. Cooke MP, Perlmutter RM (1989) Expression of a novel form of the Fyn proto-oncogene in hematopoietic cells. New Biol 1, 66-74.
13. Goldsmith JF, Hall CG, Atkinson TP (2002) Identification of an alternatively spliced isoform of the Fyn tyrosine kinase. Biochem Biophys Res Commun 298, 501-504. (Pubitemid 35333686)
14. Ingley E (2008) Srcfamily kinases: Regulationoftheir activities, levels and identification of new pathways. Biochim Biophys Acta 1784, 56-65.
15. Roskoski R Jr (2005) Src kinase regulation by phosphoryla-tion and dephosphorylation. Biochem Biophys Res Commun 331, 1-14. (Pubitemid 40545134)
16. Salter MW, Kalia LV (2004) Src kinases: A hub for NMDA receptor regulation. Nat Rev Neurosci 5, 317-328. (Pubitemid 38478658)
17. Thomas SM, Brugge JS (1997) Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 13, 513-609. (Pubitemid 28034534)
18. Vatish M, Yamada E, Pessin JE, Bastie CC (2009) Fyn kinase function in lipid utilization: A new upstream regulator of AMPK activity? Arch Physiol Biochem 115, 191-198.
19. Resh MD (1993) Interaction of tyrosine kinase oncoproteins with cellular membranes. Biochim Biophys Acta 1155, 307-322. (Pubitemid 24012297)
20. Sicheri F, Kuriyan J (1997) Structures of Src-family tyrosine kinases. Curr Opin Struct Biol 7, 777-785. (Pubitemid 28025103)
21. Jelic D, Mildner B, Kostrun S, Nujic K, Verbanac D, Culic O, Antolovic R, Brandt W (2007) Homology modeling of human Fyn kinase structure: Discoveryofrosmarinic acid as a new Fyn kinase inhibitor and in silico study of its possible binding modes. J Med Chem 50, 1090-1100. (Pubitemid 46496310)
22. Salter MW (1998) Src, N-methyl-D-aspartate (NMDA) receptors, and synaptic plasticity. Biochem Pharmacol 56, 789-798. (Pubitemid 28458972)
23. Gingrich JR, Pelkey KA, Fam SR, Huang Y, Petralia RS, Wenthold RJ, Salter MW (2004) Unique domain anchoring of Src to synaptic NMDA receptors via the mitochondrial protein NADH dehydrogenase subunit 2. Proc Natl Acad Sci USA 101, 6237-6242. (Pubitemid 38520558)
24. Osterhout DJ, Wolven A, Wolf RM, Resh MD, Chao MV (1999) Morphological differentiation of oligodendrocytes requires activation of Fyn tyrosine kinase. J Cell Biol 145, 1209-1218. (Pubitemid 29293633)
25. Hu JL, Liu G, Li YC, Gao WJ, Huang YQ (2010) Dopamine D1 receptor-mediated NMDA receptor insertion depends on Fyn but not Src kinase pathway in prefrontal cortical neurons. Mol Brain 3, 20.
26. Rajagopal R, Chao MV (2006) A role for Fyn in Trk receptor transactivation by G-protein-coupled receptor signaling. Mol Cell Neurosci 33, 36-46. (Pubitemid 44291587)
27. Yun HM, Kim S, Kim HJ, Kostenis E, Kim JI, Seong JY, Baik JH, Rhim H (2007) The novel cellular mechanism of human 5-HT6 receptor through an interaction with Fyn. J Biol Chem 282, 5496-5505. (Pubitemid 47093777)
28. Xu F, Plummer MR, Len GW, Nakazawa T, Yamamoto T, Black IB, Wu K (2006) Brain-derived neurotrophic factor rapidly increases NMDA receptor channel activity through Fyn-mediated phosphorylation. Brain Res 1121, 22-34. (Pubitemid 44708893)
29. Cheng SH, Espino PC, Marshall J, Harvey R, Merrill J, Smith AE (1991) Structural elements that regulate pp59c-Fyn catalytic activity, transforming potential, and ability to associate with polyomavirus middle-T antigen. J Virol 65, 170-179.
30. Braithwaite SP, Paul S, Nairn AC, Lombroso PJ (2006) Synaptic plasticity: One STEP at a time. Trends Neurosci 29, 452-458. (Pubitemid 44118442)
31. Nguyen TH, Liu J, Lombroso PJ (2002) Striatal enriched phosphatase 61 dephosphorylates Fyn at phosphotyrosine 420. J Biol Chem 277, 24274-24279. (Pubitemid 34951945)
32. Yeo MG, Oh HJ, Cho HS, Chun JS, Marcantonio EE, Song WK (2011) Phosphorylation of Ser 21 in Fyn regulates its kinase activity, focal adhesion targeting and is required for cell migration. J Cell Physiol 226 (1) 236-247.
33. Relucio J, Tzvetanova ID, Ao W, Lindquist S, Colog-nato H (2009) Laminin alters fyn regulatory mechanisms and promotes oligodendrocyte development. J Neurosci 29, 11794-11806.
34. Samayawardhena LA, Pallen CJ (2010) PTPalpha activates Lyn and Fyn and suppresses Hck to negatively regulate Fcepsilon RI-dependent mast cell activation and allergic responses. J Immunol 185, 5993-6002.
35. Yang X, Dutta U, Shaw LM (2010) SHP2 mediates the localized activation of Fyn downstream of the alpha6beta4 integrin to promote carcinoma invasion. Mol Cell Biol 30, 5306-5317.
36. Liu X, Brodeur SR, Gish G, Songyang Z, Cantley LC, Laudano AP, Pawson T (1993) Regulation of c-Src tyro-sine kinase activity by the Src SH2 domain. Oncogene 8, 1119-1126. (Pubitemid 23129833)
37. Yu XM, Askalan R, Keil GJ, Salter MW (1997) NMDA channel regulation by channel-associated protein tyrosine kinase Src. Science 275, 674-678. (Pubitemid 27061336)
38. Andoniou CE, Lill NL, Thien CB, Lupher ML Jr, Ota S, Bowtell DD, Scaife RM, Langdon WY, Band H (2000) The Cbl proto-oncogene product negatively regulates the Src-family tyrosine kinase Fyn by enhancing its degradation. Mol Cell Biol 20, 851-867. (Pubitemid 30044222)
39. Rao N, Ghosh AK, Douillard P, Andoniou CE, Zhou P, Band H (2002) An essential role of ubiquitination in Cbl-mediated negative regulation of the Src-family kinase Fyn. Signal Transduct 2, 29-39. (Pubitemid 36056480)
40. Malenka RC, Bear MF (2004) LTP and LTD: An embarrassment of riches. Neuron 44, 5-21. (Pubitemid 39348827)
41. Malinow R, Malenka RC (2002) AMPA receptor trafficking and synaptic plasticity. Annu Rev Neurosci 25, 103-126. (Pubitemid 34748013)
42. Minichiello L (2009) TrkB signalling pathways in LTP and learning. Nat Rev Neurosci 10, 850-860.
43. Narisawa-Saito M, Silva AJ, Yamaguchi T, Hayashi T, Yamamoto T, Nawa H (1999) Growth factor-mediated Fyn signaling regulates alpha-amino-3-hydroxy-5- methyl-4-isoxazolepropionic acid (AMPA) receptor expression in rodent neocortical neurons. Proc Natl Acad Sci USA 96, 2461-2466. (Pubitemid 29117938)
44. Ortiz O, gado-Garcia JM, Espadas I, Bahi A, Trullas R, Dreyer JL, Gruart A, Moratalla R (2010) Associative learning and CA3-CA1 synaptic plasticity are impaired in D1R null, Drd1a-/-mice and in hippocampal siRNA silenced Drd1a mice. J Neurosci 30, 12288-12300.
45. Wolf ME, Mangiavacchi S, Sun X (2003) Mechanisms by which dopamine receptors may influence synaptic plasticity. Ann NY Acad Sci 1003, 241-249. (Pubitemid 38083060)
46. Dunah AW, Sirianni AC, Fienberg AA, Bastia E, Schwarzschild MA, Standaert DG (2004) Dopamine D1-dependent trafficking of striatal N-methyl-D-aspartate glutamate receptors requires Fyn protein tyrosine kinase but not DARPP-32. Mol Pharmacol 65, 121-129. (Pubitemid 38113892)
47. Grant SG, O'Dell TJ, Karl KA, Stein PL, Soriano P, Kandel ER (1992) Impaired long-term potentiation, spatial learning, and hippocampal development in Fyn mutant mice. Science 258, 1903-1910. (Pubitemid 23026728)
48. Davis S, Laroche S (2003) What can rodent models tell us about cognitive decline in Alzheimer's disease? Mol Neuro-biol 27, 249-276. (Pubitemid 38156289)
49. Ondrejcak T, Klyubin I, Hu NW, Barry AE, Cullen WK, Rowan MJ (2010) Alzheimer's disease amyloid beta-protein and synaptic function. Neuromolecular Med 12, 13-26.
50. Selkoe DJ (2008) Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav Brain Res 192, 106-113.
51. Jiang H, Jia J (2009) Association between NR2B sub-unit gene (GRIN2B) promoter polymorphisms and sporadic Alzheimer's disease in the North Chinese population. Neu-rosci Lett 450, 356-360.
52. Liu HP, Lin WY, Liu SH, Wang WF, Tsai CH, Wu BT, Wang CK, Tsai FJ (2009) Genetic variation in N-methyl-D-aspartate receptor subunit NR3A but not NR3B influences susceptibility to Alzheimer's disease. Dement Geriatr Cogn Disord 28, 521-527.
53. Jacob CP, Koutsilieri E, Bartl J, Neuen-Jacob E, Arzberger T, Zander N, Ravid R, Roggendorf W, Riederer P, Grun-blatt E (2007) Alterations in expression of glutamatergic transporters and receptors in sporadic Alzheimer's disease. J Alzheimers Dis 11, 97-116. (Pubitemid 46376714)
54. Kurup P, Zhang Y, Venkitaramani DV, Xu J, Lombroso PJ (2010) The role of STEP in Alzheimer's disease. Channels (Austin) 4.
55. Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, Nairn AC, Salter MW, Lombroso PJ, Gouras GK, Green-gard P (2005) Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci 8, 1051-1058. (Pubitemid 41061516)
56. Hu NW, Klyubin I, Anwyl R, Rowan MJ (2009) GluN2B subunit-containing NMDA receptor antagonists prevent Abeta-mediated synaptic plasticity disruption in vivo. Proc Natl Acad Sci USA 106, 20504-20509.
57. Ronicke R, Mikhaylova M, Ronicke S, Meinhardt J, Schroder UH, Fandrich M, Reiser G, Kreutz MR, Reymann KG (2010) Early neuronal dysfunction by amyloid beta oligomers depends on activation of NR2B-containing NMDA receptors. Neurobiol Aging, doi: 10. 1016/j. neurobiolaging. 2010. 01. 011.
58. Chen BS, Roche KW (2007) Regulation of NMDA receptors by phosphorylation. Neuropharmacology 53, 362-368. (Pubitemid 47212246)
59. Nakazawa T, Komai S, Tezuka T, Hisatsune C, Umemori H, Semba K, Mishina M, Manabe T, Yamamoto T (2001) Characterization of Fyn-mediated tyrosine phosphorylation sites on GluR epsilon 2 (NR2B) subunit of the N-methyl-D-aspartate receptor. J Biol Chem 276, 693-699. (Pubitemid 32050862)
60. Nakazawa T, Komai S, Watabe AM, Kiyama Y, Fukaya M, rima-Yoshida F, Horai R, Sudo K, Ebine K, Delawary M, Goto J, Umemori H, Tezuka T, Iwakura Y, Watanabe M, Yamamoto T, Manabe T (2006) NR2B tyrosine phospho-rylation modulates fear learning as well as amygdaloid synaptic plasticity. EMBO J 25, 2867-2877. (Pubitemid 43980393)
61. Lavezzari G, McCallum J, Lee R, Roche KW (2003) Differential binding of the AP-2 adaptor complex and PSD-95 to the C-terminus of the NMDA receptor subunit NR2B regulates surface expression. Neuropharmacology 45, 729-737. (Pubitemid 38340359)
62. Prybylowski K, Chang K, Sans N, Kan L, Vicini S, Wenthold RJ (2005) The synaptic localization of NR2B-containing NMDA receptors is controlled by interactions with PDZ proteins and AP-2. Neuron 47, 845-857. (Pubitemid 41266951)
63. Roche KW, Standley S, McCallum J, Dune, Ly C, Ehlers MD, Wenthold RJ (2001) Molecular determinantsofNMDA receptor internalization. Nat Neurosci 4, 794-802.
64. Jurd R, Thornton C, Wang J, Luong K, Phamluong K, Kharazia V, Gibb SL, Ron D (2008) Mind bomb-2 is an E3 ligase that ubiquitinates the N-methyl-D-aspartate receptor NR2B subunit in a phosphorylation-dependent manner. J Biol Chem 283, 301-310.
65. Rong Y, Lu X, Bernard A, Khrestchatisky M, Baudry M (2001) Tyrosine phosphorylation of ionotropic glutamate receptors by Fyn or Src differentially modulates their susceptibility to calpain and enhances their binding to spectrin and PSD-95. J Neurochem 79, 382-390. (Pubitemid 32988954)
66. Wu HY, Hsu FC, Gleichman AJ, Baconguis I, Coulter DA, Lynch DR (2007) Fyn-mediated phosphorylation of NR2B Tyr-1336 controls calpain-mediated NR2B cleavage in neurons and heterologous systems. J Biol Chem 282, 20075-20087. (Pubitemid 47100033)
67. Hallett PJ, Spoelgen R, Hyman BT, Standaert DG, Dunah AW (2006) Dopamine D1 activation potentiates striatal NMDA receptors by tyrosine phosphorylation-dependent subunit trafficking. J Neurosci 26, 4690-4700. (Pubitemid 44315370)
68. Gu Z, Jiang Q, Fu AK, Ip NY, Yan Z (2005) Regulation of NMDA receptors by neuregulin signaling in prefrontal cortex. J Neurosci 25, 4974-4984. (Pubitemid 40712840)
69. Lau CG, Zukin RS (2007) NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci 8, 413-426. (Pubitemid 46789232)
70. Sato Y, Tao YX, Su Q, Johns RA (2008) Post-synaptic density-93 mediates tyrosine-phosphorylation of the N-methyl-D-aspartate receptors. Neuroscience 153, 700-708.
71. Tezuka T, Umemori H, Akiyama T, Nakanishi S, Yamamoto T (1999) PSD-95 promotes Fyn-mediated tyrosine phos-phorylation of the N-methyl-D-aspartate receptor subunit NR2A. Proc Natl Acad Sci USA 96, 435-440. (Pubitemid 29061226)
72. Aarts M, Liu Y, Liu L, Besshoh S, Arundine M, Gurd JW, Wang YT, Salter MW, Tymianski M (2002) Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions. Science 298, 846-850. (Pubitemid 35231541)
73. Santos SD, Carvalho AL, Caldeira MV, Duarte CB (2009) Regulation of AMPA receptors and synaptic plasticity. Neu-roscience 158, 105-125.
74. Kojima N, Wang J, Mansuy IM, Grant SG, Mayford M, Kandel ER (1997) Rescuing impairmentoflong-term poten-tiation in Fyn-deficient mice by introducing Fyn transgene. Proc Natl Acad Sci USA 94, 4761-4765. (Pubitemid 27194317)
75. Lu YF, Kojima N, Tomizawa K, Moriwaki A, Matsushita M, Obata K, Matsui H (1999) Enhanced synaptic transmission and reduced threshold for LTP induction in Fyn-transgenic mice. Eur J Neurosci 11, 75-82.
76. Abidin I, Kohler T, Weiler E, Zoidl G, Eysel UT, Lessmann V, Mittmann T (2006) Reduced presynaptic efficiency of excitatory synaptic transmission impairs LTP in the visual cortex of BDNF-heterozygous mice. Eur J Neurosci 24, 3519-3531. (Pubitemid 44952617)
77. Kojima N, Ishibashi H, Obata K, Kandel ER (1998) Higher seizure susceptibility and enhanced tyrosine phosphoryla-tion of N-methyl-D-aspartate receptor subunit 2B in Fyn transgenic mice. Learn Mem 5, 429-445. (Pubitemid 29108875)
78. Kutsuwada T, Sakimura K, Manabe T, Takayama C, Katakura N, Kushiya E, Natsume R, Watanabe M, Inoue Y, Yagi T, Aizawa S, Arakawa M, Takahashi T, Naka-mura Y, Mori H, Mishina M (1996) Impairment of suckling response, trigeminal neuronal pattern formation, and hip-pocampal LTD in NMDA receptor epsilon 2 subunit mutant mice. Neuron 16, 333-344.
79. Akashi K, Kakizaki T, Kamiya H, Fukaya M, Yamasaki M, Abe M, Natsume R, Watanabe M, Sakimura K (2009) NMDA receptor GluN2B (GluR epsilon 2/NR2B) subunit is crucial for channel function, postsynaptic macromolecular organization, and actin cytoskeleton at hippocampal CA3 synapses. J Neurosci 29, 10869-10882.
80. vonEngelhardt J, Doganci B, Jensen V, Hvalby O, Gongrich C, Taylor A, Barkus C, Sanderson DJ, Rawlins JN, Seeburg PH, Bannerman DM, Monyer H (2008) Contribution of hip-pocampal and extra-hippocampal NR2B-containing NMDA receptors to performance on spatial learning tasks. Neuron 60, 846-860.
81. Tang YP, Shimizu E, Dube GR, Rampon C, Kerchner GA, Zhuo M, Liu G, Tsien JZ (1999) Genetic enhancement of learning and memory in mice. Nature 401, 63-69.
82. Grant SG, Karl KA, Kiebler MA, Kandel ER (1995) Focal adhesion kinase in the brain: Novel subcellular localization and specific regulation by Fyn tyrosine kinase in mutant mice. Genes Dev 9, 1909-1921.
83. Yang YC, Ma YL, Chen SK, Wang CW, Lee EH (2003) Focal adhesion kinase is required, but not sufficient, for the induction of long-term potentiation in dentate gyrus neurons in vivo. J Neurosci 23, 4072-4080. (Pubitemid 36958426)
84. Hsieh H, Boehm J, Sato C, Iwatsubo T, Tomita T, Siso-dia S, Malinow R (2006) AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron 52, 831-843. (Pubitemid 44828454)
85. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539. (Pubitemid 34288854)
86. Puzzo D, Privitera L, Leznik E, Fa M, Staniszewski A, Palmeri A, Arancio O (2008) Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus. J Neurosci 28, 14537-14545.
87. Pena F, Ordaz B, Balleza-Tapia H, Bernal-Pedraza R, Marquez-Ramos A, Carmona-Aparicio L, Giordano M (2010) Beta-amyloid protein (25-35) disrupts hippocam-pal network activity: Role of Fyn-kinase. Hippocampus 20, 78-96.
88. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL (1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95, 6448-6453.
89. Williamson R, Usardi A, Hanger DP, Anderton BH (2008) Membrane-bound beta-amyloid oligomers are recruited into lipid rafts by a Fyn-dependent mechanism. FASEB J 22, 1552-1559. (Pubitemid 351656795)
90. Hoe HS, Minami SS, Makarova A, Lee J, Hyman BT, Mat-suokaY, Rebeck GW (2008) Fyn modulationofDab1 effects on amyloid precursor protein and ApoE receptor 2 processing. J Biol Chem 283, 6288-6299.
91. Gianni D, Zambrano N, Bimonte M, Minopoli G, Mercken L, Talamo F, Scaloni A, Russo T (2003) Platelet-derived growth factor induces the beta-gamma-secretase-mediated cleavage of Alzheimer's amyloid precursor protein through a Src-Rac-dependent pathway. J Biol Chem278, 9290-9297. (Pubitemid 36800413)
92. Mazanetz MP, Fischer PM (2007) Untangling tau hyper-phosphorylation in drug design for neurodegenerative diseases. Nat Rev Drug Discov 6, 464-479. (Pubitemid 47064569)
93. Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, Gerstein H, Yu GQ, Mucke L (2007) Reducing endogenous tauamelioratesamyloid beta-induceddeficits in an Alzheimer's disease mouse model. Science 316, 750-754. (Pubitemid 46717684)
94. Roberson ED, Halabisky B, Yoo JW, Yao J, Chin J, Yan F, Wu T, Hamto P, Devidze N, Yu GQ, Palop JJ, Noebels JL, Mucke L (2011) Amyloid-beta/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease. J Neurosci 31, 700-711.
95. Bhaskar K, Yen SH, Lee G (2005) Disease-related modifications in tau affect the interaction between Fyn and Tau. J Biol Chem 280, 35119-35125. (Pubitemid 41532698)
96. Derkinderen P, Scales TM, Hanger DP, Leung KY, Byers HL, Ward MA, Lenz C, Price C, Bird IN, Perera T, Kellie S, Williamson R, Noble W, Van Etten RA, Leroy K, Brion JP, Reynolds CH, Anderton BH (2005) Tyrosine 394 is phosphorylated in Alzheimer's paired helical filament tau andin fetal tau with c-Abl as the candidate tyrosine kinase. J Neurosci 25, 6584-6593. (Pubitemid 40995290)
97. Lee G, Newman ST, Gard DL, Band H, Panchamoorthy G (1998) Tau interacts with src-family non-receptor tyrosine kinases. J Cell Sci 111 (Pt 21), 3167-3177. (Pubitemid 28532427)
98. Lee G, Thangavel R, Sharma VM, Litersky JM, Bhaskar K, Fang SM, Do LH, Andreadis A, Van, Hoesen G, Ksiezak-Reding H (2004) Phosphorylation of tau by Fyn: Implications for Alzheimer's disease. J Neurosci 24, 2304-2312. (Pubitemid 38314562)
99. Lee G (2005) Tau and src family tyrosine kinases. Biochim Biophys Acta 1739, 323-330. (Pubitemid 40018548)
100. Lesort M, Jope RS, Johnson GV (1999) Insulin transiently increases tau phosphorylation: Involvement of glycogen synthase kinase-3beta and Fyn tyrosine kinase. J Neurochem 72, 576-584. (Pubitemid 29055219)
101. Scales TM, Derkinderen P, Leung KY, Byers HL, Ward MA, Price C, Bird IN, Perera T, Kellie S, Williamson R, Anderton BH, Reynolds CH (2011) Tyrosine phosphorylation of tau by the SRC family kinases lck and Fyn. Mol Neurodegener 6, 12.
102. Williamson R, Scales T, Clark BR, Gibb G, Reynolds CH, Kellie S, Bird IN, Varndell IM, Sheppard PW, Everall I, Anderton BH (2002) Rapid tyrosine phosphorylationofneu-ronal proteins including tau and focal adhesion kinase in response to amyloid-beta peptide exposure: Involvement of Src family protein kinases. J Neurosci 22, 10-20. (Pubitemid 34033478)
103. Bhaskar K, Hobbs GA, Yen SH, Lee G (2010) Tyrosine phosphorylation of tau accompanies disease progression in transgenic mouse models of tauopathy. Neuropathol Appl Neurobiol 36, 462-477.
104. Zamora-Leon SP, Lee G, Davies P, Shafit-Zagardo B (2001) Binding of Fyn to MAP-2c through an SH3 binding domain. Regulation of the interaction by ERK2. J Biol Chem 276, 39950-39958.
105. Haass C, Mandelkow E (2010) Fyn-tau-amyloid: A toxic triad. Cell 142, 356-358.
106. Ittner LM, Gotz J (2011) Amyloid-beta and tau-a toxic pas de deux in Alzheimer's disease. Nat Rev Neurosci 12, 65-72.
107. Lebouvier T, Scales TM, Williamson R, Noble W, Duy-ckaerts C, Hanger DP, Reynolds CH, Anderton BH, Derkinderen P (2009) The microtubule-associated protein tau is also phosphorylated on tyrosine. J Alzheimers Dis 18, 1-9.
108. Aleshin A, Finn RS (2010) SRC: A century of science brought to the clinic. Neoplasia 12, 599-607.
109. Hwang MK, Kang NJ, Heo YS, Lee KW, Lee HJ (2009) Fyn kinase is a direct molecular target of delphinidin for the inhibitionofcyclooxygenase-2 expression inducedbytumor necrosis factor-alpha. Biochem Pharmacol 77, 1213-1222.
110. Jung SK, Lee KW, Byun S, Kang NJ, Lim SH, Heo YS, Bode AM, Bowden GT, Lee HJ, Dong Z (2008) Myricetin suppresses UVB-induced skin cancer by targeting Fyn. Cancer Res 68, 6021-6029.
111. Meyn MA III, Smithgall TE (2008) Small molecule inhibitors of Lck: The search for specificity within a kinase family. Mini Rev Med Chem 8, 628-637.